PNA-based AOC

N/A

Report date: 2026/04/08 20:02:35

Base Information

Drug NamePNA-based AOC

Drug Alias NamePNA-based Antibody-Oligonucleotide Conjugate drug candidate for DMD

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsMuscular Dystrophy, Duchenne

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHLB Panagene Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHLB Panagene Co Ltd

Inactive CompaniesN/A

Active IndicationsMuscular Dystrophy, Duchenne

Inactive IndicationsN/A

Other Information

ATC CodeN/A